Results 281 to 290 of about 722,784 (293)

T cell drivers in NASH-HCC

Nature Reviews Cancer, 2021
exaly  

NASH

2006
openaire   +1 more source

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

Nature Reviews Gastroenterology and Hepatology, 2018
Vincent Wai-Sun Wong, Leon A Adams, Victor de Lédinghen   +2 more
exaly  

Nonalcoholic steatohepatitis (NASH) drugs market

Nature Reviews Drug Discovery, 2016
exaly  

Pharmacological agents for NASH

Nature Reviews Gastroenterology and Hepatology, 2013
Vlad Ratziu
exaly  

Obeticholic acid: towards first approval for NASH

Lancet, The, 2019
Mohammed Eslam, Letao Yang, Gamal E Shiha   +2 more
exaly  

The NASH drug dash

Nature Reviews Drug Discovery, 2015
exaly  

Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis

Molecular Cell, 2019
Henry Kuang, Tongyu Liu, Jianke Gong
exaly  

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

New England Journal of Medicine
Stephen Harrison, J M Schattenberg, Rohit Loomba   +2 more
exaly  

From NAFLD to NASH to cirrhosis—new insights into disease mechanisms

Nature Reviews Gastroenterology and Hepatology, 2013
Alexander Wree, Lori Broderick, Ali Canbay   +2 more
exaly